In fact, the effects of TRPV1 agonists/antagonists on cancer have been found to be highly complex, in that both agonists and antagonists may possess anti-cancer effects, and the effects may function via TRPV1 or independently of TRPV1 (45). Here, TRPV1 is linked to cancer.